• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Total costs of inpatient treatment for COVID-19 in a tertiary hospital in Serbia.塞尔维亚一家三级医院中新冠肺炎住院治疗的总费用。
Hippokratia. 2022 Apr-Jun;26(2):62-69.
2
Inpatient Care Costs of COVID-19 in South Africa's Public Healthcare System.南非公共医疗体系中 COVID-19 患者的住院费用。
Int J Health Policy Manag. 2022 Aug 1;11(8):1354-1361. doi: 10.34172/ijhpm.2021.24. Epub 2021 Apr 25.
3
Health care resource use and costs of two-year survivors of acute lung injury. An observational cohort study.急性肺损伤两年幸存者的医疗资源使用情况及费用。一项观察性队列研究。
Ann Am Thorac Soc. 2015 Mar;12(3):392-401. doi: 10.1513/AnnalsATS.201409-422OC.
4
Comparative Analysis of Costs of Caring for Inpatient COVID-19 Patients and Non-COVID-19 Patients at One Academic Center.比较分析一家学术中心的 COVID-19 住院患者和非 COVID-19 患者的护理成本。
South Med J. 2023 Aug;116(8):721-725. doi: 10.14423/SMJ.0000000000001590.
5
A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic "first wave" in a German tertiary care hospital.一项针对 COVID-19 患者的疾病经济负担研究，以及在德国一家三级保健医院大流行“第一波”期间使用瑞德西韦治疗的潜在成本节约的回顾性建模。
Infection. 2022 Feb;50(1):191-201. doi: 10.1007/s15010-021-01685-8. Epub 2021 Aug 18.
6
A multicentre, prospective study to evaluate costs of septic patients in Brazilian intensive care units.一项评估巴西重症监护病房脓毒症患者费用的多中心前瞻性研究。
Pharmacoeconomics. 2008;26(5):425-34. doi: 10.2165/00019053-200826050-00006.
7
Acute coronary syndromes in Europe: 1-year costs and outcomes.欧洲急性冠状动脉综合征：1年的成本与结局
Curr Med Res Opin. 2007 Mar;23(3):495-503. doi: 10.1185/030079906X167462.
8
Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications.炎症性肠病（克罗恩病和溃疡性结肠炎）：塞尔维亚的治疗成本及影响
Appl Health Econ Health Policy. 2017 Feb;15(1):85-93. doi: 10.1007/s40258-016-0272-z.
9
The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey.中国流感相关门诊就诊和住院的经济负担：一项回顾性调查。
Infect Dis Poverty. 2015 Oct 6;4:44. doi: 10.1186/s40249-015-0077-6.
10
Economic Cost of Severe Acute Respiratory Infection Associated to Influenza in Colombian Children: A Single Setting Analysis.哥伦比亚儿童流感相关严重急性呼吸道感染的经济成本：单环境分析
Value Health Reg Issues. 2019 Dec;20:159-163. doi: 10.1016/j.vhri.2019.07.010. Epub 2019 Sep 27.

引用本文的文献

1
Choosing a COVID-19 vaccination site might be driven by anxiety and body vigilance.选择新冠疫苗接种点可能受焦虑情绪和身体警觉性的影响。
Open Med (Wars). 2024 May 20;19(1):20240958. doi: 10.1515/med-2024-0958. eCollection 2024.

本文引用的文献

1
Modeling hospital energy and economic costs for COVID-19 infection control interventions.新冠病毒感染控制干预措施的医院能源与经济成本建模
Energy Build. 2021 Jul 1;242:110948. doi: 10.1016/j.enbuild.2021.110948. Epub 2021 Mar 26.
2
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline.成人 2019 冠状病毒病（COVID-19）住院患者管理：欧洲呼吸学会临床实践指南。
Eur Respir J. 2021 Apr 15;57(4). doi: 10.1183/13993003.00048-2021. Print 2021 Apr.
3
Outcomes and Mortality Among Adults Hospitalized With COVID-19 at US Medical Centers.美国医疗中心收治的 COVID-19 成年患者的结局和死亡率。
JAMA Netw Open. 2021 Mar 1;4(3):e210417. doi: 10.1001/jamanetworkopen.2021.0417.
4
Health outcomes and economic burden of hospitalized COVID-19 patients in the United States.美国住院 COVID-19 患者的健康结局和经济负担。
J Med Econ. 2021 Jan-Dec;24(1):308-317. doi: 10.1080/13696998.2021.1886109.
5
Economic burden of COVID-19, China, January-March, 2020: a cost-of-illness study.2020 年 1 月至 3 月中国 COVID-19 的经济负担：一项疾病成本研究。
Bull World Health Organ. 2021 Feb 1;99(2):112-124. doi: 10.2471/BLT.20.267112. Epub 2020 Nov 30.
6
Cost-effectiveness of intensive care for hospitalized COVID-19 patients: experience from South Africa.南非新冠肺炎住院患者重症监护的成本效益分析。
BMC Health Serv Res. 2021 Jan 22;21(1):82. doi: 10.1186/s12913-021-06081-4.
7
Economic impact of the first wave of the COVID-19 pandemic on acute care hospitals in Japan.日本 COVID-19 大流行第一波对急症护理医院的经济影响。
PLoS One. 2020 Dec 31;15(12):e0244852. doi: 10.1371/journal.pone.0244852. eCollection 2020.
8
Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs.早期 COVID-19 治疗试验：与住院时间、死亡率和相关费用的关系。
Swiss Med Wkly. 2020 Dec 31;150:w20446. doi: 10.4414/smw.2020.20446. eCollection 2020 Dec 14.
9
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
10
Survival and Estimation of Direct Medical Costs of Hospitalized COVID-19 Patients in the Kingdom of Saudi Arabia.沙特阿拉伯住院 COVID-19 患者的生存和直接医疗费用估计。
Int J Environ Res Public Health. 2020 Oct 13;17(20):7458. doi: 10.3390/ijerph17207458.

塞尔维亚一家三级医院中新冠肺炎住院治疗的总费用。

Total costs of inpatient treatment for COVID-19 in a tertiary hospital in Serbia.

作者信息

Sazdanovic P S, Milisavljevic S, Milovanovic D R, Jankovic S M, Baskic D, Ignjatovic Ristic, Ruzic Zecevic, Tomic Lucic, Djordjevic N, Jovanovic D, Stojkovic A, Lazarevic T, Begovic Cvetkovic, Kostic M J

机构信息

Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

University Clinical Centre Kragujevac, Kragujevac, Serbia.

出版信息

Hippokratia. 2022 Apr-Jun;26(2):62-69.

PMID:37188045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10177856/
Abstract

BACKGROUND

Our study aimed to identify the total costs of inpatient treatment for coronavirus disease 2019 (COVID-19) in a tertiary institution in Serbia, an upper-middle-income country in Southeast Europe.

METHODS

An observational, retrospective, cost-of-illness study was performed from the perspective of the National Health Insurance Fund and included a cohort of 78 females and 118 males admitted to the COVID-19 ward units of a tertiary center during the first wave of the pandemic.

RESULTS

The median of the total costs in the non-survivors subgroup (n =43) was 3,279.16 Euros [interquartile range (IQR): 4,023.34; range: 355.20-9,909.61) which is higher than in the survivors (n =153) subgroup 747.10 Euros (IQR: 1,088.21; 46.71-3,265.91). The cut-off value of 156.46 Euros regarding the total costs per day was estimated to have 95.3 % sensitivity and 91.5 % specificity for predicting patients' dismal prognosis, with the area under the curve (AUC) of 0.968 (95 % confidence interval: 0.940-0.996, p <0.001).

CONCLUSIONS

Direct medical inpatient treatment costs for COVID-19 represent a significant economic burden. The link between increased costs and an ultimate unfavorable outcome should be further explored.HIPPOKRATIA 2022, 26 (2):62-69.

摘要

背景

我们的研究旨在确定塞尔维亚（东南欧的一个中高收入国家）一家三级医疗机构中2019冠状病毒病（COVID-19）住院治疗的总成本。

方法

从国家健康保险基金的角度进行了一项观察性、回顾性疾病成本研究，纳入了在疫情第一波期间入住一家三级中心COVID-19病房的78名女性和118名男性队列。

结果

非幸存者亚组（n = 43）的总成本中位数为3279.16欧元[四分位间距（IQR）：4023.34；范围：355.20 - 9909.61]，高于幸存者亚组（n = 153）的747.10欧元（IQR：1088.21；46.71 - 3265.91）。估计每日总成本的临界值为156.46欧元时，预测患者不良预后的敏感性为95.3%，特异性为91.5%，曲线下面积（AUC）为0.968（95%置信区间：0.940 - 0.996，p < 0.001）。

结论

COVID-19的直接医疗住院治疗成本构成了重大经济负担。成本增加与最终不良结局之间的联系应进一步探讨。《希波克拉底》2022年，26（2）：62 - 全文共69页。 （注：原文最后页码信息表述有误，推测正确应为62 - 69页，已按推测正确内容翻译）